BMRA - Biomerica, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

BMRA

BIOMERICA, INC.

NASDAQ

$2.14

▲ UP 1.90% (0.04)

KEY STATISTICS

Market Cap$6.61 M

52w High$3.22

52w Low$1.45

Dividend Yield—

Frequency—

P/E-1.56

Volume131.25K

Shares Out.3.09M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Zackary S. Irani

COMPENSATION 2026

Salary$122,596

Stock Awards$78,438

Incentive Plan Pay$0

All Other Comp.$0

Total$201,034

ABOUT

SECTOR

Healthcare

WENT PUBLIC

September 7, 1984

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateAug 31, 2026

DayMonday

Rev. Est.$2.22M

AUG

MON

SPLIT RECORD

DATE	TYPE	RATIO
2025-04-21	Reverse	1:8
1994-11-14	Reverse	1:2
1980-12-15	Forward	3:2
1980-06-30	Forward	5:4

PRICE

$2.14 ▲ UP 1.90% (+$0.04)

OVERLAYS

About Biomerica, Inc.

https://www.biomerica.com ↗

Biomerica, Inc. develops and markets diagnostic and therapeutic products worldwide for medical conditions, including gastrointestinal diseases, food intolerances, diabetes, and COVID-19, primarily serving healthcare providers and laboratories.

INDUSTRY

Medical - Devices

A PRODUCT BIOMERICA, INC. IS KNOWN FOR

inFoods IBS

The Biomerica inFoods® IBS test is a blood-based diagnostic tool that helps physicians identify food triggers in IBS patients, enabling personalized dietary plans to potentially reduce symptoms.

COMPETITORS

COMPETITOR

Revenue by Products

PRODUCT	Q2-2022	Q3-2022	Q2-2024	Q3-2024
PhysiciansOfficeMember	$3.36M	$6.52M ▲	—	—
ClinicalLabMember	$642K	$731K ▲	—	—
Clinical Lab	—	—	$992K	$404K ▼
Contract Manufacturing	—	—	$131K	$281K ▲
OverthecounterMember	$534K	$244K ▼	—	—
ContractManufacturingMember	$112K	$167K ▲	—	—
Physicians Office	—	—	$1K	$3K ▲